Significant Reduction in Net Loss
The net loss improved by over $19 million for the year, with a reduction to $152,000 in the fourth quarter from $15.9 million in the prior period.
Positive Customer Feedback on New Products
Successfully relaunched the sleep product with an improved formula, and early customer feedback has been overwhelmingly positive. Additionally, the new Oasis Social Tonics have received outstanding early reviews.
Operational Efficiency and Cost Reduction
SG&A expenses were reduced from $24.2 million to $15.3 million for the fiscal year, demonstrating management's focus on cost structure and profitability.
Publication of Canine Study
A study was published showing that cbdMD's core blend improved pain relief and mobility in dogs, reinforcing the company's commitment to science and safety.